Metabolic syndrome: A target for preventing leukoaraiosis and age-related dementia?

Neurology

Volumn 69, Issue 10, 2007, Pages 951-952

  Furie, Karen L ^a   Smith, Eric E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ALZHEIMER DISEASE; BRAIN ATROPHY; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; DEMENTIA; DISEASE COURSE; EDITORIAL; HUMAN; LEUKOARAIOSIS; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVENTION AND CONTROL; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; WAIST CIRCUMFERENCE;

ADULT; AGED; AGING; DEMENTIA; HUMANS; LEUKOARAIOSIS; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 34548455775     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000271094.43789.0e     Document Type: Editorial

References (13)

1. Iso H, Sato S, Kitamura A, et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 2007.
2. Koren-Morag N, Goldbourt U, Tanne D. Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke 2005;36:1366-1371.
3. Kurl S, Laukkanen JA, Niskanen L, et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 2006;37:806-811.
4. Milionis HJ, Rizos E, Goudevenos J, Seferiadis K, Mikhailidis DP, Elisaf MS. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke 2005;36:1372-1376.
5. Park K, Yasuda N, Toyonaga S, Yamada SM, et al. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007;69:974-978.
6. Schmidt R, Ropele S, Enzinger C, et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian Stroke Prevention Study Ann Neurol 2005;58:610-616.
7. Liao D, Cooper L, Cai J, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study Atherosclerosis Risk in Communities Study. Stroke 1996;27:2262-2270.
8. Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246-1252.
9. Longstreth WT Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274-1282.
10. Kalmijn S, Foley D, White L, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia Aging Study. Arterioscler Thromb Vasc Biol 2000;20:2255-2260.
11. Vanhanen M, Koivisto K, Moilanen L, et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006;67:843-847.
12. Carmelli D, DeCarli C, Swan GE, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 1998;29:1177-1181.
13. Kivipelto M, Helkala EL, Laakso MP, et al. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease Ann Intern Med 2002;137:149-155.